Shamina Henkel
Psychiatry · Atlanta, GANPI 1003851494
Payments from drug & device makers
Across 461 payments — averaging $25.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$3K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$885
- Neos Therapeutics, LP$874
- Tris Pharma Inc$810
- Neurocrine Biosciences, Inc.$654
- Corium, LLC$614
- plus $5K from 24 others
What the payments were for
- Consulting fees$5505%
- Speaking & faculty fees$5004%
- Food & beverage$10,71491%
- Education$50%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 81 | $2,737 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 31 | $885 |
| Neos Therapeutics, LP | 15 | $874 |
| Tris Pharma Inc | 40 | $810 |
| Neurocrine Biosciences, Inc. | 27 | $654 |
| Corium, LLC | 28 | $614 |
| Otsuka America Pharmaceutical, Inc. | 32 | $607 |
| Johnson & Johnson | 26 | $577 |
| Axsome Therapeutics, Inc. | 15 | $567 |
| Lundbeck LLC | 34 | $551 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $551 |
| Ironshore Pharmaceuticals Inc. | 18 | $398 |
| Teva Pharmaceuticals USA, Inc. | 14 | $323 |
| Bausch Health US, LLC | 14 | $269 |
| Noven Therapeutics, LLC | 8 | $179 |
| Vanda Pharmaceuticals Inc. | 6 | $160 |
| Idorsia Pharmaceuticals US Inc | 8 | $149 |
| AbbVie(2 entities) | 6 | $137 |
| Sunovion Pharmaceuticals Inc. | 1 | $125 |
| Shire North American Group Inc | 6 | $120 |
| Collegium Pharmaceutical, Inc. | 6 | $113 |
| Adlon Therapeutics L.p. | 5 | $89 |
| Merck | 4 | $64 |
| Alfasigma USA, Inc. | 4 | $60 |
| Noven Pharmaceuticals, Inc. | 2 | $37 |
| Arbor Pharmaceuticals, Inc. | 2 | $31 |
| Avanir Pharmaceuticals, Inc. | 2 | $27 |
| Alkermes, Inc. | 1 | $25 |
| Tempus AI, Inc | 1 | $24 |
| Vertical Pharmaceuticals, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Adzenys XR-ODT$662
- Cotempla XR-ODT$662
- QELBREE$410
- CAPLYTA$248
- INGREZZA$225
- LATUDA$125
- Auvelity$125
- Quillivant$125
- Quillichew ER$125
- Dyanavel XR$125
- VYVANSE$125
- Azstarys$124
- SPRAVATO$121
- Austedo XR$106
How this compares
$11,769 in reported general payments places this provider in the 90th percentile of 900 psychiatry providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mirtazapine | 14 | $66 |
| Bupropion Hcl SrBupropion Hcl | 12 | $56 |
| Clonazepam | 12 | $29 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Atlanta
- Robert RiesenbergAtlanta$51.1M
- Saundra Maass-RobinsonAtlanta$11.1M
- David PurselleAtlanta$7.4M
- Bethany DavisAtlanta$4.4M
- Patricio Riva PosseAtlanta$884K
- Kerry ResslerAtlanta$365K
- Boadie DunlopAtlanta$345K
- Michael BurkeAtlanta$328K
- Bryon EvansAtlanta$211K
- Nurul HoqueAtlanta$145K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.